0001209191-17-046966.txt : 20170801
0001209191-17-046966.hdr.sgml : 20170801
20170801182724
ACCESSION NUMBER: 0001209191-17-046966
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170525
FILED AS OF DATE: 20170801
DATE AS OF CHANGE: 20170801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FECZKO JOSEPH M
CENTRAL INDEX KEY: 0001319874
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 17997886
MAIL ADDRESS:
STREET 1: PFIZER INC ATTN CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2017-05-25
2017-05-30
0
0001340652
ChemoCentryx, Inc.
CCXI
0001319874
FECZKO JOSEPH M
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2017-05-25
4
A
0
12912
0.00
A
82096
D
Restricted Stock Units
2017-05-25
4
D
0
12912
D
Common Stock
12912
0
D
The reporting person is amending the Form 4 originally filed to report restricted stock units awarded on May 25, 2017. The Form 4 should have reported the award as a restricted stock award. The restricted stock awarded on May 25, 2017, vests 100% on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2017-08-01